CORT Q2 2018 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$62M+75.2% YoY

Gross Profit

$61M98.1% margin

Operating Income

$21M33.1% margin

Net Income

$18M29.2% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+8.1%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$15M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$274M

Total Liabilities

$31M

Stockholders' Equity

$244M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$36M	+75.2%
Gross Profit	$61M	$35M	+75.8%
Operating Income	$21M	$13M	+61.3%
Net Income	$18M	$13M	+43.9%